Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Ukraine

Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy (13-22 Weeks LMP) in Ukraine

The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Ukraine.

Inclusion Criteria:

• Having an ongoing pregnancy of 13-22 weeks gestation
• Be willing to undergo surgical completion if necessary
• Have no contraindications to study procedures, according to provider
• Be willing and able to consent to participate in the study
• Be willing to follow study procedures

Exclusion Criteria:

• Known allergy to mifepristone or misoprostol/prostaglandin
• Any contraindications to vaginal delivery, including placenta previa
• Unable to provide consent